Skip to content
10-Q

Quarterly Report

Revolution Medicines, Inc. RVMD RVMDW

0001193125-25-266923

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 193.32M sh
Shares Diluted Q3 2025 · Sep 30, 2025 189.23M sh
Shares Diluted Q3 2025 · Sep 30, 2025 188.66M sh
Shares Diluted Q3 2025 · Sep 30, 2024 166.84M sh
Shares Diluted Q3 2025 · Sep 30, 2024 165.58M sh
Capex Q3 2025 · Sep 30, 2025 $14.07M
Capex Q3 2025 · Sep 30, 2024 $9.09M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$623.5M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$419.15M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $217.44M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $543.06M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $201.26M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.6B
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.87B
Stockholders Equity Q3 2025 · Mar 31, 2025 $2.08B
Stockholders Equity Q3 2025 · Dec 31, 2024 $2.27B
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.57B
Stockholders Equity Q3 2025 · Jun 30, 2024 $1.62B
Stockholders Equity Q3 2025 · Mar 31, 2024 $1.73B
Stockholders Equity Q3 2025 · Dec 31, 2023 $1.83B
Current Liabilities Q3 2025 · Sep 30, 2025 $245.62M
Current Liabilities Q3 2025 · Dec 31, 2024 $163.91M
Total Liabilities Q3 2025 · Sep 30, 2025 $655.02M
Total Liabilities Q3 2025 · Dec 31, 2024 $293.1M
Current Assets Q3 2025 · Sep 30, 2025 $1.98B
Current Assets Q3 2025 · Dec 31, 2024 $2.33B
Total Assets Q3 2025 · Sep 30, 2025 $2.25B
Total Assets Q3 2025 · Dec 31, 2024 $2.56B
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.61
Eps Diluted Q3 2025 · Sep 30, 2025 −$4.06
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.94
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.45
Eps Basic Q3 2025 · Sep 30, 2025 −$1.61
Eps Basic Q3 2025 · Sep 30, 2025 −$4.06
Eps Basic Q3 2025 · Sep 30, 2024 −$0.94
Eps Basic Q3 2025 · Sep 30, 2024 −$2.45
Sga Expense Q3 2025 · Sep 30, 2025 $52.76M
Sga Expense Q3 2025 · Sep 30, 2025 $128.35M
Sga Expense Q3 2025 · Sep 30, 2024 $23.96M
Sga Expense Q3 2025 · Sep 30, 2024 $69.09M
Rd Expense Q3 2025 · Sep 30, 2025 $262.51M
Rd Expense Q3 2025 · Sep 30, 2025 $692.39M
Rd Expense Q3 2025 · Sep 30, 2024 $151.75M
Rd Expense Q3 2025 · Sep 30, 2024 $404.13M
Net Income Q3 2025 · Sep 30, 2025 −$305.21M
Net Income Q3 2025 · Sep 30, 2025 −$766.41M
Net Income Q3 2025 · Jun 30, 2025 −$247.79M
Net Income Q3 2025 · Mar 31, 2025 −$213.42M
Net Income Q3 2025 · Sep 30, 2024 −$156.29M
Net Income Q3 2025 · Sep 30, 2024 −$405.52M
Net Income Q3 2025 · Jun 30, 2024 −$133.23M
Net Income Q3 2025 · Mar 31, 2024 −$116M
Operating Income Q3 2025 · Sep 30, 2025 −$315.27M
Operating Income Q3 2025 · Sep 30, 2025 −$820.74M
Operating Income Q3 2025 · Sep 30, 2024 −$175.71M
Operating Income Q3 2025 · Sep 30, 2024 −$473.21M